Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by thePlayeron Apr 02, 2018 12:06pm

174 Views

Post# 27814966

Pierre Laurin is PERSONNALLY

responsible for these multiple fiascos.
He does not care about stock price or (which is actually WORSE) is factually not capable and qualified to run the business.
He must take responsibility for this and go.

Bullboard Posts

Silvercorp to expand into Ecuador with C$200M Adventus acquisition